On Wednesday, pharmaceutical company, Dr. Reddy's Laboratories announced that it has successfully acquired specific business divisions of Wockhardt Limited's branded generics business in India and internationally in Nepal, Bhutan, Sri Lanka and Maldives. The business transfer agreement had been signed earlier this year, in February, for an upfront consideration of Rs 1,850 crore.